Immix Biopharma, Inc. (IMMX)

Last Closing Price: 7.11 (2026-11-18)

EBIT (Quarterly)

EBIT: Income before interest and taxes.

Immix Biopharma, Inc. (IMMX) had EBIT of $-15.95M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-13.93M
--
--
$15.95M
$-15.95M
$2.02M
$-13.93M
$-13.93M
$-13.93M
$-13.93M
$-13.93M
$-13.93M
EBIT
$-15.95M
$-15.83M
74.09M
74.09M
$-0.19
$-0.19
Balance Sheet Financials
$338.08M
$2.41M
$7.87M
$345.95M
$10.03M
--
$0.87M
$10.89M
$335.06M
$335.06M
$335.06M
83.81M
Cash Flow Statement Financials
$-33.87M
$-14.16M
$274.41M
$93.93M
$320.32M
$226.39M
$2.84M
--
--
Fundamental Metrics & Ratios
33.72
--
--
--
--
--
--
--
--
--
--
$-34.05M
--
--
--
--
--
--
--
-4.16%
-4.16%
-4.03%
-4.16%
$4.00
$-0.46
$-0.46